Table 3.

Multiple Logistic Regression Analysis of Patient and Provider Variables Associated With Having a PrEP Discussion During a Primary Care Visit

VariableOdds RatioP Value95% Confidence Interval
Saw MSM specialist5.050.0021.81-14.10
Documentation of STI history (positive or negative)5.410.0031.80-16.23
Documentation of condom use (consistent or inconsistent)3.320.0151.27-8.74
Age ≤40 years1.740.3400.55-5.48
African American race1.010.9800.28-3.67
  • Note: Absence of HIV testing and no sexual activity during the study period both perfectly predicted no PrEP discussion and were forced out of the model.

  • MSM, men who have sex with men; PrEP, pre-exposure prophylaxis (emtricitabine/tenofovir disoproxil fumarate [Truvada]); STI, sexually transmitted infection.